Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 522,139.92 | 29,145.39 | 1,396.71 | 104,073.46 | -666.86 | 0.15 | 22.1689 | 35.20 | 32.6134 | -122.8761 | 0.22 | 4.12 | 193.5182 | - - | ||
Maximum | - - | - - | - - | 9,731,303.00 | 444,593.00 | 12,710.00 | 1,955,691.00 | 6,978.00 | 1.00 | 268.1192 | 319.88 | 97.5200 | 69.5400 | 7.56 | 145.73 | 1,374.4000 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -99.00 | -13,707.00 | -17,092.00 | 0.00 | -183.3601 | -0.63 | -392.5400 | -4,237.3100 | -30.79 | -89.90 | 0.0000 | - - | ||
Catalent, Inc. CTLT | 60.28 | -0.04 -0.07% | 57 vs. 1,857 | 10,938.00 | 1,074.00 | -101.00 | -62.00 | -804.00 | -0.5500 | -25.4034 | 0.00 | 21.32 | -9.40 | -2.80 | -1.02 | 155.71 | 181.00 | ||
Bio-Rad Laboratories, Inc. BIO-B | 326.74 | 0.00 0.00% | 0 vs. 0 | 9,061.00 | 610.00 | 383.00 | 28.00 | 9,644.00 | 13.4600 | 6.2950 | 0.00 | 53.45 | 62.85 | 4.24 | 3.04 | 452.83 | 27.00 | ||
Teleflex Incorporated TFX | 244.71 | 3.18 1.31% | 9 vs. 413 | 11,529.00 | 737.00 | 15.00 | 72.00 | 4,109.00 | 0.3200 | 171.5370 | 0.15 | 56.40 | 2.07 | 0.34 | 0.20 | 123.43 | 47.00 | ||
IQVIA Holdings Inc. IQV | 245.31 | 2.64 1.09% | 174 vs. 1,202 | 44,720.00 | 3,740.00 | 288.00 | 377.00 | 4,980.00 | 1.5800 | 39.2964 | 0.00 | 27.59 | 7.70 | 4.54 | 1.08 | 78.10 | 182.00 | ||
Charles River Laboratories International, Inc. CRL | 210.04 | 3.94 1.91% | 34 vs. 661 | 10,844.00 | 1,011.00 | 67.00 | 50.00 | 1,959.00 | 1.4200 | 51.7491 | 0.00 | 31.65 | 6.66 | 1.85 | 0.83 | 117.76 | 51.00 | ||
West Pharmaceutical Services, Inc. WST | 317.75 | 8.57 2.77% | 41 vs. 582 | 23,049.00 | 695.00 | 115.00 | 27.00 | 3,624.00 | 1.5700 | 63.0997 | 0.05 | 33.10 | 16.58 | 4.30 | 3.20 | 173.63 | 72.00 |